NVDAcontentAD

Top Stock Picks for 2024: Gilead Sciences

GILD has outperformed on the charts but is still massively underrated by analysts

CMT, Senior Market Strategist
Jan 11, 2024 at 1:03 PM
facebook X logo linkedin


Every day for the next three weeks, we're going to highlight one of Schaeffer's top 12 picks for 2024. For today, we have pharma stock Gilead Sciences, Inc. (NASDAQ:GILD). To access the entirety of the 2024 report, click here.

The shares of pharma giant Gilead Sciences (GILD) broke out of a major basing pattern back in late 2022, which had begun forming in 2017. The equity also crossed above the round-number $100 billion market cap in December, following a year-long pullback to the rising 20-month moving average. This moving average is at the site of the stock' s 2020 peak, too.

With all this potential in place, GILD could make a move back up to it's 2015 highs within the coming calendar year. Even further, analyst sentiment could be improved upon, considering nine of the 19 covering brokerage firms still sport a tepid " hold" recommendation.

GILDTop24

 

Same-Day Trading Power: +227% YTD and Counting  — Get in for $10!

We're celebrating 44 years of helping traders win, and you can now tap into one of our most explosive services — Dynamite Day Trading Signals — for just $10.

This service was built for one thing: capturing intraday gains with precision. 

Access two highly-vetted options trades each week -  Complete with defined entries, exits, and a clear plan for same-day profits.

👉 Click Here to Learn More and Position Yourself to Take Action When the Next Alert Hits.

 

futupic

 
 
 
 

Follow us on X, Follow us on Twitter